Q4 2024 revenue of $1.5 million in pharma services; full year revenue of $1.9 millionGraftAssure RUO assay launched July ...

The test works by looking for cell-free nucleosomes in the blood. The study included 229 patients diagnosed with cancer and ...

A new urine-based biomarker test could cut in half the need for surveillance imaging to detect recurrence of the most common ...

VolitionRx (VNRX) announces the results of a study which shows that an automated Nu.Q Cancer immunoassay test in development detected a range ...

Joining us today are Oncocyte President and CEO, Josh Riggs; Chief Science Officer, Ekke Schutz; and CFO, Andrea James. We ...

The Mayo Clinic and Xact Sciences are developing an easy, noninvasive test to detect endometrial cancer in women with ...

Q4 2024 revenue of $1.5 million in pharma services; full year revenue of $1.9 millionGraftAssure RUO assay launched July ...

This screening process involves numerous assays ... damage to the system, or adversely affect assay results.

This study presents a valuable open-source and cost-effective method for automating the quantification of male aggression and courtship in Drosophila melanogaster. The work as presented provides solid ...

A home urine test demonstrated high sensitivity for detection of aggressive prostate cancer, according to study findings.The ...

Cannindah Resources Limited (ASX:CAE) is pleased to announce an outstanding assay result from the first hole in its recently commenced drilling p ...